Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Farmers Insurance

Generated: September 15, 2019

DrugPatentWatch Database Preview

Patent: 7,989,477

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,989,477
Title:Monocyclic heterocycles as kinase inhibitors
Abstract: The present invention is directed to compounds having the formula ##STR00001## and methods for using them for the treatment of cancer.
Inventor(s): Borzilleri; Robert M. (New Hope, PA), Cornelius; Lyndon A. M. (Jackson, NJ), Schmidt; Robert J. (Hainesport, NJ), Schroeder; Gretchen M. (Ewing, NJ), Kim; Kyoung S. (North Brunswick, NJ)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:12/727,534
Patent Claims:see list of patent claims

Details for Patent 7,989,477

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Sign Up Bristol-Myers Squibb Company (Princeton, NJ) 2024-04-23 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.